Q9BV10 (ALG12_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Names and origin

Protein names

Recommended name:
Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase
EC=2.4.1.260

Alternative name(s):
Asparagine-linked glycosylation protein 12 homolog
Short name=hALG12
Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase
Mannosyltransferase ALG12 homolog
Membrane protein SB87

Gene names

Name:	ALG12
ORF Names:	PP14673

Organism

Homo sapiens (Human) [Reference proteome]

Taxonomic identifier

9606 [NCBI]

Taxonomic lineage

cellular organisms › Eukaryota › Opisthokonta › Metazoa › Eumetazoa › Bilateria › Deuterostomia › Chordata › Craniata › Vertebrata › Gnathostomata › Teleostomi › Euteleostomi › Sarcopterygii › Tetrapoda › Amniota › Mammalia › Theria › Eutheria › Euarchontoglires › Primates › Haplorrhini › Simiiformes › Catarrhini › Hominoidea › Hominidae › Homininae › Homo

Protein attributes

Sequence length	488 AA.
Sequence status	Complete.
Protein existence	Evidence at protein level

General annotation (Comments)

Function	Adds the eighth mannose residue in an alpha-1,6 linkage onto the dolichol-PP-oligosaccharide precursor (dolichol-PP-Man7GlcNAc2) required for protein glycosylation.
Catalytic activity	Dolichyl beta-D-mannosyl phosphate + D-Man-alpha-(1->2)-D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-D-Man-alpha-(1->6))-D-Man-beta-(1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol = D-Man-alpha-(1->2)-D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-(1->6))-D-Man-alpha-(1->6))-D-Man-beta-(1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol + dolichyl phosphate.
Pathway	Protein modification; protein glycosylation.
Subcellular location	Endoplasmic reticulum membrane; Multi-pass membrane protein Probable.
Tissue specificity	Expressed in fibroblasts.
Involvement in disease	Congenital disorder of glycosylation 1G (CDG1G) [MIM:607143]: A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.1 Ref.8 Ref.9 Ref.10 Ref.11
Sequence similarities	Belongs to the glycosyltransferase 22 family.
Sequence caution	The sequence AAM94900.1 differs from that shown. Reason: Frameshift at position 468.

Ontologies

Keywords
Cellular component	Endoplasmic reticulum Membrane
Coding sequence diversity	Polymorphism
Disease	Congenital disorder of glycosylation Disease mutation
Domain	Transmembrane Transmembrane helix
Molecular function	Glycosyltransferase Transferase
Technical term	Complete proteome Reference proteome
Gene Ontology (GO)
Biological_process	GPI anchor biosynthetic process Inferred from electronic annotation. Source: InterPro dolichol-linked oligosaccharide biosynthetic process Inferred from direct assay Ref.1. Source: MGI post-translational protein modification Traceable author statement. Source: Reactome protein N-linked glycosylation via asparagine Traceable author statement. Source: Reactome protein folding Non-traceable author statement Ref.8. Source: UniProtKB
Cellular_component	endoplasmic reticulum membrane Traceable author statement. Source: Reactome integral to membrane Inferred from electronic annotation. Source: UniProtKB-KW intrinsic to endoplasmic reticulum membrane Inferred from electronic annotation. Source: InterPro
Molecular_function	alpha-1,6-mannosyltransferase activity Inferred by curator Ref.8. Source: UniProtKB dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity Inferred from electronic annotation. Source: EC
Complete GO annotation...

Sequence annotation (Features)

	Feature key	Position(s)	Length	Description	Graphical view	Feature identifier
Molecule processing
	Chain	1 – 488	488	Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase		PRO_0000215781
Regions
	Transmembrane	11 – 31	21	Helical; Potential
	Transmembrane	68 – 88	21	Helical; Potential
	Transmembrane	93 – 113	21	Helical; Potential
	Transmembrane	122 – 142	21	Helical; Potential
	Transmembrane	145 – 165	21	Helical; Potential
	Transmembrane	177 – 197	21	Helical; Potential
	Transmembrane	212 – 232	21	Helical; Potential
	Transmembrane	264 – 284	21	Helical; Potential
	Transmembrane	290 – 310	21	Helical; Potential
	Transmembrane	312 – 332	21	Helical; Potential
	Transmembrane	346 – 366	21	Helical; Potential
	Transmembrane	423 – 443	21	Helical; Potential
Natural variations
	Natural variant	67	1	T → M in CDG1G. Ref.8		VAR_017904
	Natural variant	101	1	G → R in CDG1G. Ref.11		VAR_038428
	Natural variant	142	1	F → V in CDG1G. Ref.1 Corresponds to variant rs28942090 [ dbSNP | Ensembl ].		VAR_017905
	Natural variant	146	1	R → Q in CDG1G. Ref.8 Ref.11		VAR_017906
	Natural variant	158	1	L → P in CDG1G. Ref.9		VAR_017907
	Natural variant	393	1	I → V. Ref.7 Corresponds to variant rs3922872 [ dbSNP | Ensembl ].		VAR_024466
Experimental info
	Sequence conflict	267	1	A → T in AAM94900. Ref.2

Sequences

	Sequence		Length	Mass (Da)
	Q9BV10 [UniParc]. Last modified June 1, 2001. Version 1. Checksum: 8D4F921C21CBC8B6	FASTA	488	54,655
	10 20 30 40 50 60 MAGKGSSGRR PLLLGLLVAV ATVHLVICPY TKVEESFNLQ ATHDLLYHWQ DLEQYDHLEF 70 80 90 100 110 120 PGVVPRTFLG PVVIAVFSSP AVYVLSLLEM SKFYSQLIVR GVLGLGVIFG LWTLQKEVRR 130 140 150 160 170 180 HFGAMVATMF CWVTAMQFHL MFYCTRTLPN VLALPVVLLA LAAWLRHEWA RFIWLSAFAI 190 200 210 220 230 240 IVFRVELCLF LGLLLLLALG NRKVSVVRAL RHAVPAGILC LGLTVAVDSY FWRQLTWPEG 250 260 270 280 290 300 KVLWYNTVLN KSSNWGTSPL LWYFYSALPR GLGCSLLFIP LGLVDRRTHA PTVLALGFMA 310 320 330 340 350 360 LYSLLPHKEL RFIIYAFPML NITAARGCSY LLNNYKKSWL YKAGSLLVIG HLVVNAAYSA 370 380 390 400 410 420 TALYVSHFNY PGGVAMQRLH QLVPPQTDVL LHIDVAAAQT GVSRFLQVNS AWRYDKREDV 430 440 450 460 470 480 QPGTGMLAYT HILMEAAPGL LALYRDTHRV LASVVGTTGV SLNLTQLPPF NVHLQTKLVL LERLPRPS

References

	« Hide 'large scale' referencesShow 'large scale' references »
[1]	"Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase." Chantret I., Dupre T., Delenda C., Bucher S., Dancourt J., Barnier A., Charollais A., Heron D., Bader-Meunier B., Danos O., Seta N., Durand G., Oriol R., Codogno P., Moore S.E.H. J. Biol. Chem. 277:25815-25822(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT CDG1G VAL-142. Tissue: Skin.
[2]	"Identification of novel membrane proteins." Zhang W., Li N., Wan T., Cao X. Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[3]	"Large-scale cDNA transfection screening for genes related to cancer development and progression." Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X. , Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., Gu J. Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
[4]	"A genome annotation-driven approach to cloning the human ORFeome." Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A., Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J., Beare D.M., Dunham I. Genome Biol. 5:R84.1-R84.11(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
[5]	"The DNA sequence of human chromosome 22." Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M. , Buck D., Burgess J., Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A., Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C., Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L., Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L., Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N., Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R., Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y., Wright H. Nature 402:489-495(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[6]	Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. , Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C. Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[7]	"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT VAL-393. Tissue: Eye.
[8]	"ALG12 mannosyltransferase defect in congenital disorder of glycosylation type Ig." Grubenmann C.E., Frank C.G., Kjaergaard S., Berger E.G., Aebi M., Hennet T. Hum. Mol. Genet. 11:2331-2339(2002) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION OF VARIANTS CDG1G MET-67 AND GLN-146.
[9]	"Deficiency of dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl mannosyltransferase causes congenital disorder of glycosylation type Ig." Thiel C., Schwarz M., Hasilik M., Grieben U., Hanefeld F., Lehle L., von Figura K., Koerner C. Biochem. J. 367:195-201(2002) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION OF VARIANT CDG1G PRO-158.
[10]	"Abnormal glycosylation of red cell membrane band 3 in the congenital disorder of glycosylation Ig." Zdebska E., Bader-Meunier B., Schischmanoff P.-O., Dupre T., Seta N., Tchernia G., Koscielak J., Delaunay J. Pediatr. Res. 54:224-229(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN CDG1G.
[11]	"Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality." Kranz C., Basinger A.A., Guecsavas-Calikoglu M., Sun L., Powell C.M., Henderson F.W., Aylsworth A.S., Freeze H.H. Am. J. Med. Genet. A 143:1371-1378(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CDG1G ARG-101 AND GLN-146.

Web resources

GeneReviews

GGDB

GlycoGene database

Cross-references

Sequence databases
EMBL GenBank DDBJ	AJ290427 mRNA. Translation: CAC83681.1. AJ303120 mRNA. Translation: CAC67488.1. AF311904 mRNA. Translation: AAM94900.1. Frameshift. AF318343 mRNA. Translation: AAL55850.1. CR456369 mRNA. Translation: CAG30255.1. AL671710 Genomic DNA. Translation: CAO72064.1. CH471138 Genomic DNA. Translation: EAW73480.1. BC001729 mRNA. Translation: AAH01729.1. BC098562 mRNA. Translation: AAH98562.1.
IPI	IPI00012208.
RefSeq	NP_077010.1. NM_024105.3.
UniGene	Hs.526711.
3D structure databases
ProteinModelPortal	Q9BV10.
ModBase	Search...
Protein-protein interaction databases
IntAct	Q9BV10. 2 interactions.
STRING	9606.ENSP00000333813.
Protein family/group databases
CAZy	GT22. Glycosyltransferase Family 22.
PTM databases
PhosphoSite	Q9BV10.
Polymorphism databases
DMDM	45476971.
Proteomic databases
PaxDb	Q9BV10.
PRIDE	Q9BV10.
Protocols and materials databases
DNASU	79087.
StructuralBiologyKnowledgebase	Search...
Genome annotation databases
Ensembl	ENST00000330817; ENSP00000333813; ENSG00000182858.
GeneID	79087.
KEGG	hsa:79087.
UCSC	uc003biy.3. human.
Organism-specific databases
CTD	79087.
GeneCards	GC22M050296.
H-InvDB	HIX0175449.
HGNC	HGNC:19358. ALG12.
HPA	HPA051665.
MIM	607143. phenotype. 607144. gene.
neXtProt	NX_Q9BV10.
Orphanet	79324. ALG12-CDG syndrome.
PharmGKB	PA134987771.
GenAtlas	Search...
Phylogenomic databases
eggNOG	NOG256776.
HOGENOM	HOG000265945.
HOVERGEN	HBG050486.
InParanoid	Q9BV10.
KO	K03847.
OMA	WLSAFAI.
OrthoDB	EOG4F7NK5.
PhylomeDB	Q9BV10.
Enzyme and pathway databases
BRENDA	2.4.1.130. 2681.
Reactome	REACT_17015. Metabolism of proteins.
UniPathway	UPA00378.
Gene expression databases
Bgee	Q9BV10.
CleanEx	HS_ALG12.
Genevestigator	Q9BV10.
GermOnline	ENSG00000182858. Homo sapiens.
Family and domain databases
InterPro	IPR005599. GPI_mannosylTrfase. [Graphical view]
PANTHER	PTHR22760. PTHR22760. 1 hit.
Pfam	PF03901. Glyco_transf_22. 1 hit. [Graphical view]
ProtoNet	Search...
Other
ChiTaRS	ALG12. human.
GenomeRNAi	79087.
NextBio	67909.
SOURCE	Search...

Entry information

Entry name

ALG12_HUMAN

Accession

Primary (citable) accession number: Q9BV10
Secondary accession number(s): A6PWM1 , Q4KMH4, Q8NG10, Q96AA4

Entry history

Integrated into UniProtKB/Swiss-Prot:	March 15, 2004
Last sequence update:	June 1, 2001
Last modified:	May 29, 2013
This is version 111 of the entry and version 1 of the sequence. [Complete history]

Entry status

Reviewed (UniProtKB/Swiss-Prot)

Annotation program

Chordata Protein Annotation Program

Disclaimer

Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.